Zura Bio (ZURA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.88, -9.35% vs the prior close of $4.28.
- Volume 4.88M shares, 2.1x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ZURA slides 9.3% to $3.88, a 3-month low on 2.1x normal volume. Closed at $3.88, -9.35% vs the prior close of $4.28. Day range $3.86–$4.35, opened at $4.30.
ZURA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ZURA slides 9.3% to $3.88, a 3-month low on 2.1x normal volume
- Closed at $3.88, -9.35% vs the prior close of $4.28. Day range $3.86–$4.35, opened at $4.30.
- Volume was 4.88M shares, 2.1x its 50-day average of 2.36M — unusually heavy trading.
- Price is -22.8% vs its 50-day average ($5.03) and -26.8% vs its 200-day average ($5.30).
- 52-week range $3.15–$7.44; today's close sits at 17% of that range, 47.8% below the 52-week high.
Oct 15, 2026 — ZURA dips 2.9% to $4.28 on 2.2x normal volume
- Closed at $4.28, -2.95% vs the prior close of $4.41. Day range $4.15–$4.50, opened at $4.42.
- Volume was 4.99M shares, 2.2x its 50-day average of 2.28M — unusually heavy trading.
- Price is -15.5% vs its 50-day average ($5.07) and -19.4% vs its 200-day average ($5.31).
- 52-week range $3.15–$7.44; today's close sits at 26% of that range, 42.5% below the 52-week high.
Oct 14, 2026 — ZURA jumps 4.3% to $4.41 on 2.6x normal volume
- Closed at $4.41, +4.26% vs the prior close of $4.23. Day range $4.17–$4.61, opened at $4.23.
- Volume was 5.75M shares, 2.6x its 50-day average of 2.18M — unusually heavy trading.
- Price is -13.4% vs its 50-day average ($5.09) and -17.0% vs its 200-day average ($5.31).
- 52-week range $3.15–$7.44; today's close sits at 29% of that range, 40.7% below the 52-week high.
Oct 13, 2026 — ZURA jumps 5.8% to $4.23 on 14.4x normal volume
- Closed at $4.23, +5.75% vs the prior close of $4.00. Day range $3.85–$4.78, opened at $3.95.
- Volume was 24.44M shares, 14.4x its 50-day average of 1.70M — unusually heavy trading.
- Price is -17.3% vs its 50-day average ($5.12) and -20.4% vs its 200-day average ($5.31).
- 52-week range $3.15–$7.44; today's close sits at 25% of that range, 43.1% below the 52-week high.
Oct 12, 2026 — ZURA ends flat (+0.0%) to $4.00, 3 down days in a row
- Closed at $4.00, +0.00% vs the prior close of $4.00. Day range $3.94–$4.12, opened at $4.00.
- Volume was 1.61M shares, 1.0x its 50-day average of 1.67M.
- Price is -22.2% vs its 50-day average ($5.14) and -24.7% vs its 200-day average ($5.32).
- 52-week range $3.15–$7.44; today's close sits at 20% of that range, 46.2% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — ZURA slides 3.1% to $4.00
- Closed at $4.00, -3.15% vs the prior close of $4.13. Day range $4.00–$4.35, opened at $4.13.
- Volume was 1.71M shares, 1.0x its 50-day average of 1.65M.
- Price is -22.7% vs its 50-day average ($5.17) and -24.8% vs its 200-day average ($5.32).
- 52-week range $3.15–$7.44; today's close sits at 20% of that range, 46.2% below the 52-week high.
Oct 8, 2026 — ZURA dips 1.0% to $4.13
- Closed at $4.13, -0.96% vs the prior close of $4.17. Day range $3.90–$4.16, opened at $4.12.
- Volume was 2.70M shares, 1.7x its 50-day average of 1.60M.
- Price is -20.6% vs its 50-day average ($5.20) and -22.3% vs its 200-day average ($5.32).
- 52-week range $3.15–$7.44; today's close sits at 23% of that range, 44.5% below the 52-week high.
Oct 7, 2026 — ZURA jumps 5.3% to $4.17
- Closed at $4.17, +5.30% vs the prior close of $3.96. Day range $3.90–$4.35, opened at $3.96.
- Volume was 2.08M shares, 1.3x its 50-day average of 1.57M.
- Price is -20.2% vs its 50-day average ($5.23) and -21.6% vs its 200-day average ($5.32).
- 52-week range $3.15–$7.44; today's close sits at 24% of that range, 44.0% below the 52-week high.
Oct 6, 2026 — ZURA rises 0.8% to $3.96
- Closed at $3.96, +0.76% vs the prior close of $3.93. Day range $3.82–$4.05, opened at $3.97.
- Volume was 1.43M shares, 0.9x its 50-day average of 1.55M.
- Price is -24.6% vs its 50-day average ($5.25) and -25.6% vs its 200-day average ($5.32).
- 52-week range $3.15–$7.44; today's close sits at 19% of that range, 46.8% below the 52-week high.
Oct 5, 2026 — ZURA slides 4.4% to $3.93, a 3-month low, 3 down days in a row
- Closed at $3.93, -4.38% vs the prior close of $4.11. Day range $3.92–$4.19, opened at $4.11.
- Volume was 2.65M shares, 1.8x its 50-day average of 1.51M.
- Price is -25.6% vs its 50-day average ($5.28) and -26.1% vs its 200-day average ($5.32).
- 52-week range $3.15–$7.44; today's close sits at 18% of that range, 47.2% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — ZURA dips 0.7% to $4.11 on 2.0x normal volume
- Closed at $4.11, -0.72% vs the prior close of $4.14. Day range $4.07–$4.36, opened at $4.21.
- Volume was 2.95M shares, 2.0x its 50-day average of 1.45M — unusually heavy trading.
- Price is -22.6% vs its 50-day average ($5.31) and -22.8% vs its 200-day average ($5.32).
- 52-week range $3.15–$7.44; today's close sits at 22% of that range, 44.8% below the 52-week high.
ZURA latest news & SEC filings
Every SEC filing by or about ZURA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 18, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 17, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 13, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$26.30M (prior year -$15.99M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.21 (prior year -$0.17) (loss widened vs Jun 30, 2025)
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 22, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade ZURA
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 19, 2026, Feb 26, 2026. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.90% (largest 9.3%).
- Liquidity: about 3.76M shares (≈$14.59M) trade per day on average.
- 52-week position: $3.88 vs a range of $3.15–$7.44 (17% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: Industries Holdings Llc Access bought 2,000,000 shares on Feb 26, 2026.
- Latest filings: 8-K Aug 17, 2026; 8-K Aug 11, 2026; 10-Q Aug 11, 2026.
- Share count: 95.83M shares outstanding (Aug 11, 2026), +47.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
ZURA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.30 | 4.35 | 3.86 | 3.88 | 4.88M |
| Oct 15, 2026 | 4.42 | 4.50 | 4.15 | 4.28 | 4.99M |
| Oct 14, 2026 | 4.23 | 4.61 | 4.17 | 4.41 | 5.75M |
| Oct 13, 2026 | 3.95 | 4.78 | 3.85 | 4.23 | 24.44M |
| Oct 12, 2026 | 4.00 | 4.12 | 3.94 | 4.00 | 1.61M |
| Oct 9, 2026 | 4.13 | 4.35 | 4.00 | 4.00 | 1.71M |
| Oct 8, 2026 | 4.12 | 4.16 | 3.90 | 4.13 | 2.70M |
| Oct 7, 2026 | 3.96 | 4.35 | 3.90 | 4.17 | 2.08M |
| Oct 6, 2026 | 3.97 | 4.05 | 3.82 | 3.96 | 1.43M |
| Oct 5, 2026 | 4.11 | 4.19 | 3.92 | 3.93 | 2.65M |
| Oct 2, 2026 | 4.21 | 4.36 | 4.07 | 4.11 | 2.95M |
| Oct 1, 2026 | 4.13 | 4.24 | 4.00 | 4.14 | 2.91M |
| Sep 30, 2026 | 4.04 | 4.23 | 3.98 | 4.16 | 3.33M |
| Sep 29, 2026 | 4.10 | 4.19 | 3.92 | 4.00 | 2.04M |
| Sep 28, 2026 | 4.03 | 4.19 | 3.92 | 4.10 | 1.47M |
| Sep 25, 2026 | 4.27 | 4.28 | 3.91 | 4.04 | 1.51M |
| Sep 24, 2026 | 4.32 | 4.32 | 3.84 | 4.16 | 3.43M |
| Sep 23, 2026 | 4.53 | 4.55 | 4.16 | 4.33 | 2.06M |
| Sep 22, 2026 | 4.56 | 4.62 | 4.45 | 4.51 | 2.15M |
| Sep 21, 2026 | 4.55 | 4.55 | 4.37 | 4.50 | 1.11M |
About Zura Bio
Zura Bio (ZURA) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in LA JOLLA, CA. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1855644.
ZURA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Daniel J. Becker | Director | Jun 22, 2026 |
| Mark Eisner | Director | Jun 22, 2026 |
| Jennifer Jarrett | Director | Jun 22, 2026 |
| Sandeep Chidambar Kulkarni | Chief Executive Officer | Apr 2, 2026 |
| Amit Munshi | Director | Jun 22, 2026 |
| Ajay Nirula | Director | Jun 22, 2026 |
| Steven J Schoch | Director | Jun 22, 2026 |
| Parvinder Thiara | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kim Davis | Chief Legal Officer | Apr 2, 2026 |
| Eric J Hyllengren | Chief Financial Officer | Apr 2, 2026 |
| Sandeep Chidambar Kulkarni | Chief Executive Officer | Apr 2, 2026 |
| Marlyn Teresa Mathew | VP, Principal Acctg. Officer | Jun 22, 2026 |
| Kiran Nistala | See Remarks | Apr 2, 2026 |
| Gary Whale | Chief Technology Officer | Apr 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Feb 26, 2026 | Industries Holdings Llc Access | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Industries Holdings Llc Access | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Biotechnology Llc Ai | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Biotechnology Llc Ai | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Len Blavatnik | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Len Blavatnik | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Industries Management, Llc Access | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Industries Management, Llc Access | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Industries Holdings Llc Access | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Industries Holdings Llc Access | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Biotechnology Llc Ai | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Biotechnology Llc Ai | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Len Blavatnik | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Len Blavatnik | Buy | 2,000,000 | $6.25 |
| Feb 26, 2026 | Industries Management, Llc Access | Buy | 2,000,000 | $6.25 |
ZURA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-68.65M | -1.06 | $-64.81M |
| Dec 31, 2024 | — | $-52.40M | -0.60 | $-28.08M |
| Dec 31, 2023 | — | $-60.36M | -2.09 | $-15.05M |
| Dec 31, 2022 | — | $-25.74M | -141.97 | $-1.20M |
Latest balance sheet: total assets $213.40M, total liabilities $16.32M, cash $205.13M (as of Jun 30, 2026).
ZURA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $5.56 |
| May 7, 2026 | 8-K Item 2.02 (results) | $4.54 |
| Mar 19, 2026 | 8-K Item 2.02 (results) | $6.12 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $6.77 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $4.18 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $1.72 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.26 |
| Mar 25, 2025 | 8-K Item 2.02 (results) | $1.49 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $4.47 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ZURA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.